P H Van der Meide

Author PubWeight™ 28.03‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Monoclonal antibodies to human immune interferon and their use in a sensitive solid-phase ELISA. J Immunol Methods 1985 1.62
2 Treatment with gamma-interferon triggers the onset of collagen arthritis in mice. Arthritis Rheum 1988 1.44
3 The elongation factor EF-Tu and its two encoding genes. Prog Nucleic Acid Res Mol Biol 1983 1.37
4 Mutants of Escherichia coli altered in both genes coding for the elongation factor Tu. Proc Natl Acad Sci U S A 1978 1.22
5 Bidirectional activating signals between Trypanosoma brucei and CD8+ T cells: a trypanosome-released factor triggers interferon-gamma production that stimulates parasite growth. Eur J Immunol 1991 1.14
6 Induction, maintenance, and reinduction of tumoricidal activity in bone marrow-derived mononuclear phagocytes by Corynebacterium parvum. Evidence for the involvement of a T cell- and interferon-gamma-independent pathway of macrophage activation. J Immunol 1987 1.01
7 Interferon-gamma in vivo. Induction and loss of class II MHC antigens and immature myelomonocytic cells in rat organs. Eur J Immunol 1988 1.00
8 Elongation factor Tu isolated from Escherichia coli mutants altered in TufA and tufB. Proc Natl Acad Sci U S A 1980 0.97
9 Alteration in the level of interferon-gamma results in acceleration of Theiler's virus-induced demyelinating disease. J Neuroimmunol 1994 0.97
10 Enhancement of DTH reaction and inhibition of the expression of class II transplantation antigens by in vivo treatment with antibodies against gamma-interferon. Clin Exp Immunol 1988 0.95
11 Regulation of MHC expression in vivo. II. IFN-alpha/beta inducers and recombinant IFN-alpha modulate MHC antigen expression in mouse tissues. J Immunol 1989 0.93
12 In vivo treatment with interferon-gamma during early pregnancy in mice induces strong expression of major histocompatibility complex class I and II molecules in uterus and decidua but not in extra-embryonic tissues. Biol Reprod 1992 0.93
13 Complexities of applying nasal tolerance induction as a therapy for ongoing relapsing experimental autoimmune encephalomyelitis (EAE) in DA rats. Clin Exp Immunol 1998 0.93
14 Recombinant IL-4 aggravates experimental autoimmune uveoretinitis in rats. J Immunol 1996 0.92
15 Interferon-gamma-like immunoreactivity in certain neurons of the central and peripheral nervous system. J Neurosci Res 1989 0.92
16 Cytotoxicity of tumor necrosis factor for thyroid epithelial cells and its regulation by interferon-gamma. Eur J Immunol 1987 0.91
17 Suppression and augmentation of rat adjuvant arthritis with monoclonal anti-interferon-gamma antibody. Clin Exp Immunol 1989 0.90
18 Molecular properties of two mutant species of the elongation factor Tu. Eur J Biochem 1981 0.89
19 Nasal tolerance in experimental autoimmune myasthenia gravis (EAMG): induction of protective tolerance in primed animals. Clin Exp Immunol 1998 0.88
20 Interferon-gamma (IFN-gamma) and IL-4 expressed during mercury-induced membranous nephropathy are toxic for cultured podocytes. Clin Exp Immunol 1995 0.88
21 Specific prolongation of MHC class II disparate skin allografts by in vivo administration of anti-IFN-gamma monoclonal antibody. J Immunol 1990 0.87
22 Interferon-gamma induces class II MHC antigens on RINm5F cells. Diabetes 1988 0.84
23 Binding of monomeric immunoglobulins by bone marrow-derived mononuclear phagocytes; its modulation by interferon-gamma. Eur J Immunol 1990 0.84
24 Schwann cells co-cultured with stimulated T cells and antigen express major histocompatibility complex (MHC) class II determinants without interferon-gamma pretreatment: synergistic effects of interferon-gamma and tumor necrosis factor on MHC class II induction. Eur J Immunol 1989 0.83
25 Placental MHC class I antigen expression is induced in mice following in vivo treatment with recombinant interferon-gamma. J Reprod Immunol 1991 0.83
26 Cellular mRNA expression of interferon-gamma (IFN-gamma), IL-4 and IL-10 relates to resistance to experimental autoimmune myasthenia gravis (EAMG) in young Lewis rats. Clin Exp Immunol 1997 0.80
27 Q beta replicase containing wild type and mutant tufA and tufB gene. J Biol Chem 1980 0.79
28 Pharmacokinetic studies with human and rat interferons-gamma in different species. J Interferon Res 1986 0.79
29 Interferon-gamma-like immunoreactivity and T-cell marker expression in rat skeletal muscle fibres. Brain Res 1989 0.77
30 Immunohistochemical characterisation of immunological changes at the tumour site after chemo-immunotherapy with doxorubicin, interleukin-2 and interferon-gamma. Anticancer Res 1996 0.75
31 Prevention of myelosuppression does not improve the therapeutic efficacy of chemo-immunotherapy. Anticancer Res 1992 0.75